Share Prices & Company Research

Stockbroking

Smith & Nephew

Current Price 1099.75p Bid 1100.00p Ask 1101.50p Change 0.34%
Last Updated: 31/10/2024 07:58. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. It is focused on the repair, regeneration and replacement of soft and hard tissue. It operates through three segments: Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that helps surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue.

Financial Highlights Year Ended 31/12/2019

Revenue
£5,138.00m
Operating Profit/Loss
£815.00m
Dividend yield (%)
1.50
Total dividend for year
$0.3750
Dividend cover
2.73
P/E Ratio
24.00
More Financials

Key Personnel

Dr Deepak Nath
Chief Executive Officer
Mr John Rogers
Chief Financial Officer
Mr Jeremy (Jez) Maiden
Independent Non-Executive Director
Mr Marc Owen
Independent Non-Executive Director
Mr Rupert Soames
Independent Non-Executive Director
Mr Simon Lowth
Independent Non-Executive Director
Mrs Angie Risley
Independent Non-Executive Director
Dr John Ma
Non-Executive Director
Mr Bob White
Non-Executive Director
Ms Jo Hallas
Non-Executive Director
Ms Katarzyna Mazur Hofsaess
Non-Executive Director

Stock Details

EPIC
SNL
ISIN
GB0009223206
Shares in Issue
896.62m
Market cap
£9,860.52m

Analyst Views (1)

Strong Buy
 
0%
Buy
 
100.00%
Hold
 
0%
Sell
 
0%
Strong Sell
 
0%
This information is provided by Web Financial Group (UK) Limited. It is subject to change without notice and doesn't reflect the views held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
1,099.75p
Bid Price
1,100.00p
Ask Price
1,101.50p
Volume
819,266
Change Today
3.75p
% Change Today
0.34%
Open
1,096.50p
Previous Close
1,099.75p
Intraday High
1,107.50p
Intraday Low
1,083.50p
52 Week High
1,207.75p
52 Week Low
923.40p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

More Charts

Income Statement

Year End Date
31 Dec 2019
31 Dec 2018
 
$ (M)
$ (M)
Continuing Operations
Revenue
5,138.00
4,904.00
Operating Profit/Loss
815.00
863.00
Net Interest
-55.00
-51.00
Pre-Tax Profit
743.00
871.00
Profit After Tax from continuing operations
600.00
663.00
Discontinued Operations
Profit After Tax
n/a
n/a
Profit/Loss for the Year
600.00
663.00
Attributable to:
Equity Holders of Parent Company
600.00
663.00
Minority Interests
n/a
n/a
Total Dividend Paid
$0.3750
$0.3600
Retained Profit/(Loss) for the Financial Year
n/a
n/a

Earnings per Share

Year End Date
31 Dec 2019
31 Dec 2018
Basic
68.60c
76.00c
Diluted
68.40c
75.70c
Adjusted
102.20c
100.90c
Dividend per Share
$0.3750
$0.3600

Assets

Year End Date
31 Dec 2019
31 Dec 2018
 
$ (M)
$ (M)
Non-Current Assets
Property, Plant & Equipment
1,323.00
1,062.00
Intangible Assets
4,356.00
3,547.00
Investment Properties
n/a
n/a
Investments
110.00
139.00
Other Financial Assets
n/a
n/a
Other Non-Current Assets
291.00
234.00
Current Assets
Inventories
1,614.00
1,395.00
Trade & Other Receivables
1,328.00
1,317.00
Cash at Bank & In Hand
277.00
365.00
Current Asset Investments
n/a
n/a
Other Current Assets
n/a
n/a
Other Assets
n/a
n/a
Total Assets
9,299.00
8,059.00

Liabilities

Year End Date
31 Dec 2019
31 Dec 2018
 
$ (M)
$ (M)
Current Liabilities
Borrowings
72.00
164.00
Other Current Liabilities
1,492.00
1,301.00
Total Current Liabilities
1,564.00
1,465.00
Non-Current Liabilities
Borrowings
1,975.00
1,301.00
Provisions
381.00
252.00
Other Non-Current Liabilities
238.00
167.00
Total Non-Current Liabilities
2,594.00
1,720.00
Other Liabilities
n/a
n/a
Total Liabilities
4,158.00
3,185.00

Net Assets

Year End Date
31 Dec 2019
31 Dec 2018
 
$ (M)
$ (M)
Net Assets
5,141.00
4,874.00

Capital & Reserves

Year End Date
31 Dec 2019
31 Dec 2018
 
$ (M)
$ (M)
Share Capital
177.00
177.00
Share Premium Account
610.00
608.00
Other Reserves
-495.00
-536.00
Retained Earnings
4,849.00
4,625.00
Shareholders Funds
5,141.00
4,874.00
Minority Interests/Other Equity
n/a
n/a
Total Equity
5,141.00
4,874.00

Dividend History

Type
Ex-Dividend Date
Payment Date
Payment
Interim
03 Oct 2024
08 Nov 2024
14.40¢
Final
01 Apr 2024
22 May 2024
23.10¢
Final
28 Mar 2024
22 May 2024
23.10¢
Interim
05 Oct 2023
01 Nov 2023
14.40¢
Final
30 Mar 2023
17 May 2023
23.10¢
Interim
29 Sep 2022
26 Oct 2022
14.40¢
Final
31 Mar 2022
11 May 2022
23.10¢
Interim
30 Sep 2021
27 Oct 2021
14.40¢
Final
01 Apr 2021
12 May 2021
23.10¢
Interim
01 Oct 2020
28 Oct 2020
14.40¢
Final
02 Apr 2020
06 May 2020
23.10¢
Interim
03 Oct 2019
30 Oct 2019
14.40¢
Final
04 Apr 2019
08 May 2019
22.00¢
Interim
04 Oct 2018
31 Oct 2018
14.00¢
Final
05 Apr 2018
09 May 2018
22.70¢
Interim
05 Oct 2017
01 Nov 2017
12.30¢
Final
30 Mar 2017
10 May 2017
18.50¢
Interim
06 Oct 2016
25 Oct 2016
12.30¢
Final
21 Apr 2016
11 May 2016
19.00¢
Interim
08 Oct 2015
27 Oct 2015
11.80¢

Dividend Metrics

Year End Date
31 Dec 2019
31 Dec 2018
Dividend growth
4.17%
2.86%
Dividend yield
1.50%
1.80%
Dividend cover
2.73
2.80


Cboe Global Markets® is a registered trade mark of Cboe Global Markets, Inc., a company incorporated in the United States of America with registered address at 400 South LaSalle Street, Chicago, IL 60605, USA. Cboe shall own any and all rights including without limitation Intellectual Property rights and any and all goodwill arising directly or indirectly out of the Recipient’s use of the “Cboe Global Markets®”, “Cboe®” and “Bats®”” trademarks. Neither Cboe nor its licensors accept any liability for any errors or omissions in the Cboe Europe Indices or underlying data. No further distribution of Cboe Europe data is permitted without Cboe’s express written consent.

The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.